Results
Title

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma.

Authors

Jiang, Shiyao; Huang, Jingjing; He, Hua; Liu, Yueying; Liang, Lu; Sun, Xiaoyan; Li, Yi; Cong, Li; Qing, Bei; Jiang, Yiqun

Subjects

ADENOCARCINOMA; LUNG cancer; EPIDERMAL growth factor receptors; ERLOTINIB; PROTEIN-tyrosine kinase inhibitors; GENOMES; CELL lines; DRUG resistance in cancer cells

Publication

Cancers, 2022, Vol 14, Issue 18, pN.PAG

ISSN

2072-6694

Publication type

Academic Journal

DOI

10.3390/cancers14184395